Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Subcutaneous delivery enables predictable absorption
4 Commonly used for type 2 diabetes and weight management, it acts on receptors in the brain, gut, and fat tissue, influencing appetite, blood sugar, and how the body handles fat
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for several indications: type 2 diabetes management (under the brand names Ozempic and Rybelsus), chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity (under the brand name Wegovy), and in adolescents aged 12 years and older with obesity
10.1136/mp.54.5.311 170 LaufsU.WassmannS.CzechT.MnzelT.EisenhauerM.BhmM.et al (2005)
Explained what she was doing
The occurrence of GI AEs has led some clinicians to question whether the weight loss observed with semaglutide treatment may be primarily a result of these side effects [52]
